Market Overview

Zynerba Higher Despite Q3 Miss

Share:
Related ZYNE
Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week
Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week

Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) shares are trading higher by $1.07 at $13.18 in Tuesday's session. Despite a Q3 EPS miss of 4 cents, the stock is trading in the green.

After a lower open, Zynerba immediately found support at $11.40 and began to move higher. That low coincides with Friday's low of $11.30. As of 3:06 p.m. EST, the ensuing rally found resistance just above Monday's high ($13.66), reaching $13.74. In order to fill the void price from its August 4 session, it will need to reach $13.83.

On the following day, the stock swooned to $6.67 from its $15.06 close following a disappointing Phase 2 trial of ZYN002 for treatment of adult epileptic patients with focal seizures.

Posted-In: Technicals Intraday Update Movers Trading Ideas

 

Related Articles (ZYNE)

View Comments and Join the Discussion!

For Apple, Does X Mark The Spot?

Jim Chanos Adds To Tesla Short, Thinks Musk Will Step Down By 2020